Hocine Ait Mohand

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

Li Ts, Roland Tubiana, Christine Katlama et al. · The Lancet · 1998 · 555 citations

Life Sciences, Immunology, Infectious Diseases +16

Genotypic Inhibitory Quotient as Predictor of Virological Response to Ritonavir-Amprenavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients

Anne‐Geneviève Marcelin, C. Lamotte, Constance Delaugerre et al. · Antimicrobial Agents and Chemotherapy · 2003 · 98 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patients

Anne‐Geneviève Marcelin, Dissou Affolabi, C. Lamotte et al. · Journal of Medical Virology · 2004 · 26 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Improvement of HIV-associated neurocognitive disorders after antiretroviral therapy intensification: the Neuro+3 study

Gilles Force, Idir Ghout, Jacques Ropers et al. · Journal of Antimicrobial Chemotherapy · 2020 · 18 citations

Pharmacy, Neurology, Pharmacotherapy +16

Comparison of the Dynamics of Resistance-Associated Mutations to Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, and Protease Inhibitors after Cessation of Antiretroviral Combination Therapy

Marc Wirden, Constance Delaugerre, Anne‐Geneviève Marcelin et al. · Antimicrobial Agents and Chemotherapy · 2004 · 16 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17